Corona Virus

FDA chief calls for probe of relationship between agency and Biogen

The decision to greenlight Aduhelm has drawn widespread scrutiny, and came over the objections of independent advisers to the FDA and other experts who said there was little evidence of its effectiveness.Read More

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Most Popular

To Top